Given the important role of CCR2 during inflammatory processes after MI, the aim of the present study was to investigate whether blocking CCR2 by the specific antagonist propagermanium (PPG) [14] prevents a long-lasting and overwhelming inflammatory reaction, thereby leading to reduced scar formation and improved myocardial function in a mouse model of MI. Here, CCR2 is linked to myocardial infarction.